Quantellect · Analysts · Analyst Profile
Analyst rating accuracy & track record
Sean McCutcheon does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 VIRVir Biotechnology Inc | Buy | $12.00 | Jul 2025 | +55.6% | Miss |
 JANXJanux Therapeutics Inc | Buy | $65.00 | Jul 2025 | −59.4% | Miss |
 CMPXCompass Therapeutics Inc. | Buy | $9.00 | Jul 2025 | −36.2% | Miss |
 BDTXBlack Diamond Therapeutics Inc | Buy | $11.00 | Jul 2025 | −48.6% | Miss |
 LEGNLegend Biotech Corp | Buy | $86.00 | Jun 2025 | −15.2% | Miss |
 ENGNenGene Holdings Inc. Common Stock | Buy | $23.00 | Nov 2024 | −15.6% | Miss |
 XNCRXencor Inc | Buy | $40.00 | Jun 2024 | −48.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.